Researchers at the University of Tennessee Health Science Center working with colleagues at the University of New Mexico have identified three drugs, already approved for other uses in humans, as possible therapeutics for COVID-19, the illness caused by the SARS-CoV-2 virus. November 18: Citizen Tribune November 18: Fox5 Vegas November 18: USA Life Sciences Database… Read More
Congressman Steve Cohen (TN-09) today announced that the University of Tennessee Health Science Center (UTHSC) will receive a $228,000 grant from the National Institute of Allergy and Infectious Diseases for research on biosynthetic enzymes.
As is the case elsewhere, COVID conditions are worsening quickly in Shelby County. On Tuesday, 835 new cases were reported, making it the county’s worst day heretofore. In the past seven days alone, about 1 in 315 county residents have been diagnosed with COVID. Dr. Jon McCullers — the Pediatrician-in-Chief at Le Bonheur Children’s Hospital… Read More
Since the COVID-19 pandemic swept the world in early 2020, many scientists in the viral research community have shifted their focus to study the SARS-CoV-2 coronavirus. Dr. Colleen Jonsson is one of them. She’s the Director of the Regional Biocontainment Laboratory, and Director of the Institute for the Study of Host-Pathogen Systems at the University… Read More
“The goal is to keep people out of the hospital. We are very, very hopeful,” said Dr. Scott Strome, executive dean of the College of Medicine at University of Tennessee Health Science Center. “Our numbers are going through the roof.”
Moderna Inc. is the second pharmaceutical in a week to announce that an independent monitoring board has found its vaccine highly effective against COVID-19. Moderna’s Phase 3 showed 94.5% efficacy. Last Monday, Pfizer’s Phase 3 vaccine showed a 90% success rate in fighting the virus. The FDA has said it would accept vaccines that showed… Read More
Seventeen years ago, Stevie Moore’s son was shot and killed with an assault rifle. On Saturday, Moore stood up in front of a crowd estimated at 420 people, holding a picture of Prentice Moore, his son. “This is my child,” he told the crowd filling the parking lot between Shelby County Juvenile Court and the… Read More
St. Jude Children’s Research Hospital and the University of Tennessee Health Science Center are recruiting adult participants for a phase 3 COVID-19 vaccine clinical trial. More information about the trial, including participant eligibility requirements, is available here. The two are partnering to offer a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s… Read More
